EX-23.1 7 tm2022878d2_ex23-1.htm EXHIBIT 23.1

 

Exhibit 23.1

 

Consent of Independent Registered Public Accounting Firm

 

We hereby consent to the incorporation by reference in this Registration Statement on Form S-3 of Milestone Pharmaceuticals Inc. of our report dated March 5, 2020 relating to the consolidated financial statements, which appears in Milestone Pharmaceuticals Inc.’s Annual Report on Form 10-K for the year ended December 31, 2019. We also consent to the reference to us under the heading “Experts” in the Registration Statement on Form S-3.

 

/s/ PricewaterhouseCoopers LLP 1
Montréal, Québec, Canada
June 19, 2020

  

 

1 CPA auditor, CA, public accountancy permit No. A113048